secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2021-10-14T23:59:59+00:00
Accession:  0001654954-21-011071
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Zivo Bioscience reports shareholder votes: directors elected, equity plan approved, auditor ratified
--------------------------------------------------------------------------------

- All five director nominees elected with >95% votes for (excluding broker non-votes).
- Ratification of Wolinetz, Lafazan & Company as auditor approved with 98% of votes cast.
- 2021 Equity Incentive Plan approved with ~90% of votes for (excluding broker non-votes).
- Advisory say-on-pay approved with ~94% of votes for (excluding broker non-votes).
- 60.6% of outstanding shares represented at the annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495421011071/0001654954-21-011071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495421011071/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-21-011071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer